novel btk inhibitors: overcoming intolerance, resistance, and other challenges in b-cell cancers
Published 2 years ago • 475 plays • Length 1:00:33Download video MP4
Download video MP3
Similar videos
-
1:00:00
novel btk inhibitors: overcoming intolerance, resistance, and other challenges in b-cell cancers
-
22:36
progress with btk inhibitors: a journey through the mechanisms of covalent and noncovalent options
-
2:19
overcoming btk resistance with non-covalent btki
-
3:41
resistance to btk inhibitors in b-cell malignancies
-
1:36:53
new standards for cll care with btk inhibitors
-
1:32:21
solving the puzzles for b-cell malignancies: navigating the place of btk inhibitors today and tom...
-
8:20
btki inhibitors in the treatment of b-cell lymphoma - deborah stephens session
-
1:25:33
customizing care in cll with btk inhibitors
-
1:03:37
interprofessional perspectives on safety management with targeted therapy for b-cell malignancies
-
1:02:27
personalized treatment with emerging btk inhibitor options in cll/sll and mcl
-
39:22
improving on the past: using next-generation btk inhibitors effectively in b-cell malignancies
-
21:28
targeting btk and bcl-2 for b-cell malignancies: where are we moving toward?
-
7:17
the future of btk inhibition in b-cell lymphomas
-
1:26:59
transforming care with btk inhibitors in cll
-
59:40
challenges and changes with targeted options in cll
-
2:02
dr. allan on the use of vecabrutinib therapy in b-cell malignancies
-
52:31
rationale, evidence, and practical potential for btk inhibitors in patient-centered ms care
-
1:17
dr. woyach on btk inhibition and the mechanism of action of ibrutinib
-
1:32
selecting btk inhibitors for patients with mcl